Lenalidomide (Revlimid) for Multiple Myeloma, Mantle Cell Lymphoma and Myelodysplastic Syndromes скачать в хорошем качестве

Lenalidomide (Revlimid) for Multiple Myeloma, Mantle Cell Lymphoma and Myelodysplastic Syndromes

Lenalidomide (Revlimid) for Multiple Myeloma, Mantle Cell Lymphoma and Myelodysplastic Syndromes https://www.medindia.net/doctors/drug... Lenalidomide is an immunomodulatory agent which modifies either Immune response (or) function of the immune system. Lenalidomide helps the bone marrow in producing normal blood cells and kills abnormal cells in bone marrow. Lenalidomide is popularly known as Revlimid, Lenalid, Lenangio, Ladevina. Lenalidomide is prescribed to treat multiple myeloma (Bone marrow cancer), mantle cell lymphoma, myelodysplastic syndrome (MDS), multiple myeloma after a hematopoietic stem-cell transplant (HCST) Please help us translate this video in your language to make it more universal and useful to your language community. We present useful and essential information on the drug lenalidomide that everyone should know when taking this drug. Use Medindia drug information to check drug to drug interactions if you are taking more than one drug. Share your comments if you are experiencing any unusual side effects. Social Media Handles: Instagram:   / medindia   Facebook:   / medindia   Twitter:   / medindia   LinkedIn :  / medindia   Tumblr :  / medindia   Languages: Medindia English: https://medindia.net/ Medindia Hindi: https://hi.medindia.net/ Medindia French: https://fr.medindia.net/ Medindia Spanish: https://es.medindia.net/ Medindia Chinese: https://cn.medindia.net/